Claus Tycho Bræstrup
Algemeen Directeur bij Kastan ApS
Oorsprong van het eerstegraads netwerk van Claus Tycho Bræstrup
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
University of Copenhagen
56
| College/University | Other Consumer Services | 56 |
| Public Company | Pharmaceuticals: Major | 37 | |
| Public Company | Pharmaceuticals: Major | 34 | |
| Public Company | Pharmaceuticals: Major | 22 | |
Tekniikan Akatemia -säätiö sr
 Tekniikan Akatemia -säätiö sr Investment Trusts/Mutual FundsMiscellaneous Tekniikan Akatemia -säätiö sr, also known as Technology Academy Finland (TAF), is based in Helsinki, Finland. The CEOs of the Finnish company are Mikko Salaspuro and Ainomaija Susanna Haarla. TAF awards the €1 million Millennium Technology Prize and organizes associated events and initiatives. The private company provides an international meeting ground for corporate life, academia, and policymakers, and promotes Finland's position in the community. The Millennium Technology Prize is the world's most prestigious award for breakthrough innovations that improve the quality of people's lives.
16
| Private Company | Investment Trusts/Mutual Funds | 16 |
| Public Company | Food: Specialty/Candy | 15 | |
UCB Pharma GmbH
 UCB Pharma GmbH Pharmaceuticals: MajorHealth Technology UCB Pharma GmbH manufactures and develops drugs. It manufactures prescription and non-prescription drugs. With its partners, the company engages in biopharmaceutical research and development. Apart from providing medication, the company provides support to the patients. The company was founded in 1928 and is headquartered in Monheim, Germany.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
Aniona ApS
 Aniona ApS Medical/Nursing ServicesHealth Services Aniona ApS is a private company based in Ballerup, Denmark. Jørgen Drejer has been the CEOs since incorporation. The Danish company was founded by Thomas Feldthus, Anker Gunvald Lundemose, Claus Tycho Bræstrup, Jørgen Drejer.
4
| Private Company | Medical/Nursing Services | 4 |
Bayer Schering Pharma AG
4
| Extinct | Medical Specialties | 4 |
Saniona A/S
 Saniona A/S Miscellaneous Commercial ServicesCommercial Services Part of Saniona AB, Saniona A/S is a Danish company dedicated to improving the lives of rare disease patients worldwide through scientific innovation. The company focuses on Prader-Willi Syndrome, a rare genetic disorder characterized by insatiable appetite, abnormal growth and body composition, low muscle tone, and social/emotional/cognitive deficits. Saniona is a leader in the discovery of highly specific ion channel modulators, which is a validated approach to treating diseases such as diabetes, hypertension, and epilepsy. The company's robust ion channel drug discovery engine has led to the development of San711, a first-in-class positive allosteric modulator of GABAA ?3 receptors, and San903, a potential first-in-class inhibitor of the calcium-activated potassium ion channel, KCA3.1, both of which are in development for rare neuropathic, inflammatory, and fibrotic disorders.
1
| Subsidiary | Miscellaneous Commercial Services | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Claus Tycho Bræstrup via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| Technical University of Denmark | College/University | Graduate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree Doctorate Degree Graduate Degree Undergraduate Degree Doctorate Degree Corporate Officer/Principal Doctorate Degree Graduate Degree | |
| Copenhagen Business School | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Corporate Officer/Principal Undergraduate Degree Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Graduate Degree | |
| University of Aarhus | College/University | Doctorate Degree Undergraduate Degree Corporate Officer/Principal Graduate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Chairman Public Communications Contact Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
| CARLSBERG A/S | Beverages: Alcoholic | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chairman | |
Novo Nordisk Fonden
 Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Novo Nordisk Fonden provides basis for the commercial and research activities conducted by the companies. It also supports scientific and humanitarian purposes activities. It awards grants for research within biomedicine, biotechnology, general practice and family medicine, nursing, and art history at public research institutions. It bridges gap between the discoveries made by researchers in biomedicine and biotechnology and their commercial application. The company was founded by August Krogh, Marie Krogh, Harald Pedersen, Hans Christian Hagedorn, August Kongsted and Thorvald Pedersen in 1922 and is headquartered in Hellerup, Denmark. | Investment Trusts/Mutual Funds | Chairman Chief Executive Officer Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member | |
Bavarian Nordic GmbH
 Bavarian Nordic GmbH BiotechnologyHealth Technology Part of Bavarian Nordic A/S, Bavarian Nordic GmbH engages in research and development in biotechnology for cancer and infectious diseases. The company is based in Martinsried, Germany. The German company was founded in 2014. Paul Chaplin has been the CEO of the company since 1999. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chairman Director/Board Member | |
| SANA AB | Biotechnology | Founder Founder Director/Board Member Chief Executive Officer Director/Board Member | |
Novo Nordisk Ltd.
 Novo Nordisk Ltd. Medical/Nursing ServicesHealth Services Novo Nordisk Ltd. engages in the sale and marketing of pharmaceutical products for the treatment of chronic conditions in the United Kingdom. It offers medicines for the treatment of diabetes, and hemophilia and bleeding disorders, as well as for growth hormone therapy and hormone replacement therapy. The company is headquartered in Crawley, the United Kingdom. | Medical/Nursing Services | Director/Board Member Director/Board Member Chief Executive Officer Chief Operating Officer Director/Board Member | |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Founder Director/Board Member Chief Executive Officer Founder | |
Elinkeinoelämän Keskusliitto ry
 Elinkeinoelämän Keskusliitto ry Miscellaneous Commercial ServicesCommercial Services Elinkeinoelämän Keskusliitto ry is a business organization based in Helsinki, Finland. and has subsidiaries in Finland. The Finnish company operates as a business organization. The CEO of the private company is Jyri Jukka Häkämies. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Novo Ventures 1 A/S
 Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures (Novo Ventures) is a venture capital operating division of Novo Nordisk Fonden. It engages in investment activities. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Investment Managers | Private Equity Investor Director of Investments Private Equity Investor Corporate Officer/Principal | |
East Office of Finnish Industries Oy
 East Office of Finnish Industries Oy Miscellaneous Commercial ServicesCommercial Services East Office of Finnish Industries Oy operates as a business association. The private company is based in Helsinki, Finland. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member Director/Board Member Chairman | |
| Aalto University | College/University | Corporate Officer/Principal Director/Board Member Graduate Degree Corporate Officer/Principal | |
Carlsberg Breweries A/S
 Carlsberg Breweries A/S Beverages: AlcoholicConsumer Non-Durables Carlsberg Breweries A/S engages in the production and marketing of beer and soft drinks. The firm's brands include Afsana, Backyard Brew, CELIA, Dahls, and Eriksberg. It operates through the following geographical segments: Western Europe; Asia; Eastern Europe; and Central and Eastern Europe. The company was founded by Jacob Christian Jacobsen in 1847 and is headquartered in Copenhagen, Denmark. | Beverages: Alcoholic | Chairman Director/Board Member Director/Board Member Chairman | |
Teknologiateollisuus ry
 Teknologiateollisuus ry Miscellaneous Commercial ServicesCommercial Services Teknologiateollisuus ry operates as a lobbying organization for technology industry companies. It promotes the competitiveness of the Finnish technology industries and communicates about the diversity and significance of the industries. The company was founded on September 13, 1978 and is headquartered in Helsinki, Finland. | Miscellaneous Commercial Services | Chairman Director/Board Member Director/Board Member Director/Board Member | |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | President Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| ORSTED A/S | Electric Utilities | Director/Board Member Director/Board Member Chief Executive Officer | |
Bioneer A/S
 Bioneer A/S Pharmaceuticals: MajorHealth Technology Bioneer A/S develops and manufactures drugs. The firm's products and services drug development, molecular histology, dynamic gastric model, biomarkers and drug targets, protein manufacturing, mammalian cell technology, immune targeting, active ingredients and microorganisms. The company was founded in 2003 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
Danfoss A/S
 Danfoss A/S Industrial MachineryProducer Manufacturing Danfoss A/S operates as an engineering company. The firm manufactures refrigeration, air conditioning, and industrial controls for several industries. Its products include thermostatic expansion valves, solenoid, pressure and temperature regulators, electronic controls, line components, electronically operated, coils, solenoid, pressure controls and thermostats, filter driers, sight glasses, contactors and motor starters, liquid level controls, condensing units, appliance, controls accessories and spare parts, compressors for air conditioning, heating and refrigeration, heat exchangers, and valve station. It operates through the following segments: Danfoss Power Solutions, Danfoss Climate Solutions, Danfoss Power Electronics and Drives, and Other Areas. The Danfoss Power Solutions segment establishes electric powertrain systems. The Danfoss Climate Solutions segment includes heating and cooling solutions for buildings, cold chains, industry, and infrastructure. The Danfoss Power Electronic and Drives segment focuses on the decarbonization with electric and energy solutions for vehicles and industry. The company was founded by Peter Johan Mads Clausen on September 1, 1933 and is headquartered in Nordborg, Denmark. | Industrial Machinery | Director/Board Member Director/Board Member Director/Board Member | |
| FORWARD PHARMA A/S | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Founder | |
| ALK-ABELLÓ A/S | Biotechnology | Director/Board Member Chief Executive Officer Chairman | |
| The Danish Academy of Technical Sciences | College/University | President Corporate Officer/Principal Corporate Officer/Principal | |
| Danmarks Farmaceutiske Universitet | College/University | Undergraduate Degree Graduate Degree Director/Board Member | |
Lundbeck Pharma A/S
 Lundbeck Pharma A/S Medical DistributorsDistribution Services Lundbeck Pharma A/S markets and sells medicines within Central Nervous System. It specializes in various illnesses and conditions such as depression, Schizophrenia, anxiety, alcohol dependence, and Parkinson's and Alzheimer's diseases. The company was founded on January 1, 1988 and is headquartered in Valby, Denmark. | Medical Distributors | Chief Executive Officer Chairman General Counsel | |
| Steno Diabetes Center A/S | Chairman Chairman Director/Board Member | ||
| New York University | College/University | Graduate Degree Graduate Degree Graduate Degree | |
| KONECRANES OYJ | Trucks/Construction/Farm Machinery | Chief Executive Officer Chief Executive Officer Sales & Marketing | |
| NOKIA OYJ | Telecommunications Equipment | Chief Tech/Sci/R&D Officer Chief Executive Officer Public Communications Contact | |
The Carlsbergfondet Foundation
 The Carlsbergfondet Foundation Financial ConglomeratesFinance Carlsbergfondet Foundation engages in the financing and promotion of art and art sciences. The company was founded by J. C. Jacobsen in 1876 and is headquartered in Copenhagen, Denmark. | Financial Conglomerates | Director/Board Member Director/Board Member Director/Board Member | |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Director/Board Member | |
| GENMAB A/S | Pharmaceuticals: Major | Chairman Director/Board Member Chairman | |
| BIOHIT OYJ | Medical Specialties | Director/Board Member Founder Director/Board Member | |
| University of Helsinki | College/University | Graduate Degree Graduate Degree Corporate Officer/Principal | |
| University of Southern Denmark | College/University | Graduate Degree Graduate Degree Corporate Officer/Principal | |
| WNTRESEARCH AB | Pharmaceuticals: Other | Chief Executive Officer Director of Finance/CFO Corporate Officer/Principal | |
Bertelsmann Management SE
 Bertelsmann Management SE Miscellaneous Commercial ServicesCommercial Services Bertelsmann Management SE is an international media enterprise with corporate divisions including RTL Group, Penguin Random House, and Gruner + Jahr. The private company is based in Gütersloh, DE and has a global presence of subsidiaries in several regions. The German company's Press Center provides detailed information for journalists, and the company is also committed to Corporate Responsibility activities. Thomas Hermann Rabe has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| SANOFI | Biotechnology | Director/Board Member Corporate Officer/Principal | |
InnovationsFonden
 InnovationsFonden Investment ManagersFinance InnovationsFonden provides investment services. It invests in entrepreneurs, researchers, and businesses. The company was founded on January 4, 2005 and is headquartered in Copenhagen, Denmark. | Investment Managers | Chief Executive Officer Director/Board Member | |
Evolva SA
 Evolva SA Miscellaneous Commercial ServicesCommercial Services Evolva SA is a Swiss-headquartered, international pharmaceutical biotech company focused on the discovery and development of drugs based on its distinctive and proprietary genetic chemistry platform. The company was founded in Switzerland in 2004 based on US/Danish technology. Evolva is headquartered in Allschwil/Basel with operations in Denmark, India and the USA. The Company has raised CHF 38.2 million of equity to date and employs 75 persons of whom 30 are based in Allschwil. The firm's strategy and business approach is based on five pillars that offer a sustainable development path for creating a successful company, which include Building a balanced portfolio. Evolva focuses on orally available small molecules in the belief that they are more convenient for patients and more cost-effective both from manufacture and administration points of view for the society, focus on differentiated pharmaceutical products with major benefits. Focusing on cardiovascular/renal and infectious diseases. Together they cause more than 50% of all deaths worldwide. Most of the top 20 pharmaceutical companies are active in both sectors, and all are active in one of the two sectors - hence widening Evolva's opportunities to partner. Building technology platform as the source of this differentiation. Evolva finds different structures with different properties from those found by the 99% of the industry that focuses on synthetic chemistry or proteins. Openness to unusual markets. The biotech business model has changed. As well as the established markets new opportunities arise in emerging countries such as India and China, and in adjacent sectors such as treatments against potential bio-terrorist and bio-warfare agents and the production of pharmaceutical and industrial chemical intermediates. Cost-effective implementation. Evolva places different functions around the globe according to where local conditions best suit. This approach both reduces Evolva's cost base and increases access to revenues, partners and talent. Evolva sees revenues and partners as important because they provide additional flexibility, resources and talent. Also, they provide important opportunities to better understand, and better meet, the needs of current and future customers. | Miscellaneous Commercial Services | Founder Director/Board Member | |
| BERTELSMANN SE & CO. KGAA | Movies/Entertainment | Director/Board Member Director/Board Member | |
Fertin Pharma A/S
 Fertin Pharma A/S Food: Specialty/CandyConsumer Non-Durables Fertin Pharma A/S develops and manufactures medical chewing gum. It offers pharmaceutical and nutraceutical chewing gum products. The company was founded in 1915 and is headquartered in Vejle, Denmark. | Food: Specialty/Candy | Director/Board Member Director/Board Member |
Statistieken
Internationaal
| Denemarken | 31 |
| Finland | 10 |
| Duitsland | 4 |
| Verenigde Staten | 3 |
| Verenigd Koninkrijk | 2 |
Sectoraal
| Health Technology | 17 |
| Consumer Services | 11 |
| Commercial Services | 7 |
| Consumer Non-Durables | 6 |
| Finance | 5 |
Operationeel
| Director/Board Member | 672 |
| Chairman | 240 |
| Corporate Officer/Principal | 223 |
| Independent Dir/Board Member | 140 |
| Chief Executive Officer | 111 |
Sterkste connecties
| Insiders | |
|---|---|
| Erik Gregers Hansen | 40 |
| Jack Nielsen | 38 |
| Henrik Poulsen | 37 |
| Bo Jesper Hansen | 34 |
| Harry Penner | 31 |
| Anders Hedegaard | 30 |
| Stig Gustavson | 29 |
| Thomas Fulton Wilson McKillop | 28 |
| Niels Henrik Jensen | 26 |
| Peter Andersen | 26 |
| Jørgen Drejer | 26 |
| Pekka Ilmari Lundmark | 25 |
| Bruce Carter | 25 |
| Leif Vejhe Djurhuus | 25 |
| Anker Gunvald Lundemose | 25 |
- Beurs
- Insiders
- Claus Tycho Bræstrup
- Bedrijfsconnecties